Elman Bio
Elman Bio7About
What does Elman Bio do?
Elman Bio is a biotechnology company focused on developing a new platform for the discovery and development of novel therapeutics. Their approach aims to accelerate the identification and validation of drug candidates, potentially leading to more effective treatments for various diseases.
Is Elman Bio trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Elman Bio is 52 out of 100, based on site security posture and privacy practices.
Where is Elman Bio headquartered?
Elman Bio is headquartered in London, United Kingdom.
When was Elman Bio founded?
Elman Bio was founded in 2026.
What industry does Elman Bio operate in?
Elman Bio operates in Biotech, Drug Discovery, HealthTech, Therapeutics, Platform.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Leading AI agency in Guwahati specializing in biological intelligence, generative AI, and regulatory systems for Asia's underrepresented populations.
Spearmint Resources Inc. is a Canadian mineral exploration company focused on lithium, gold, and antimony projects.
Eccoscience is a startup focused on developing AI-powered solutions for scientific research and discovery.
Feef is a voice-native AI agent that designs personalized fitness, nutrition, supplement, and recovery protocols, integrating them directly into your calendar.
Longevity and metabolic health platform offering personalized insights and interventions.
AI-powered platform for personalized health and longevity.
An entrant is a company tagged Biotech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 1 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.